At Cipla, we are not mere manufacturers of medication. What we make are memories. Memories that may not have been there to be remembered, had a life not been lived. We make people better and we save lives. 

We want people to live a long, healthy and happy life.

Some call it human care, we call it ‘Caring For life’.

Cipla South Africa is one of the largest pharmaceutical companies in South Africa by volume and third largest by value. We hope to bring relief to the lives of cancer patients with our range of quality products at affordable prices to ensure equitable access to medication.

For more info about Cipla, visit www.cipla.co.za.

Cipla’s history

Our story has never been only about making medicines, but also about making a difference in the lives of the patients we serve.

Cipla – established in 1935 – is a global pharmaceutical company focused on agile and sustainable growth, complex generics, and deepening portfolio in our home markets of India, South Africa, North America, and key regulated and emerging markets.

We are trusted by healthcare professionals and patients across the world. Over the last 86 years, we have strengthened our leadership in the pharmaceutical industry and fortified our promise of ‘Caring for Life’. As a responsible corporate citizen, Cipla’s humanitarian approach to healthcare in pursuit of its purpose of ‘Caring for Life’ and deep-rooted community links wherever it is present make it a partner of choice to global health bodies, peers and all stakeholders.

Manufacturing excellence – Made in Africa, for Africa

Cipla is committed to making the highest quality, affordable, life-saving medicines because we want people to live a long and healthy life. We see a future where good health is expected – not for the few but for the many. That’s why we believe no-one should be denied access to essential medicine. We’re not just about making medicine, we’re about making a difference.

Cipla’s goal is to produce pharmaceutical products of the highest quality that have minimal environmental impact, adhere strictly to Good Manufacturing Practices (cGMP) and Good Laboratory Practices (GLP), and numerous other international regulatory standards at our WHO-compliant facility. 

Cipla continually strives to produce quality, affordable medicines that will meet the demands of the increasing African population.